Clinical Trial Update: Hypofractionated Radiotherapy With 3.5 Gy Per Fraction for Early Glottic Cancer

View source ↗

Summary

This clinical trial evaluates hypofractionated radiotherapy delivering 3.5 Gy per fraction for early glottic cancer. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glottic Cancer

Snippet

Sponsor: Assiut University | Conditions: Early Glottic Cancer | Status: NOT_YET_RECRUITING